Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 1997

View Archived Issues

Recordati announces 1996 consolidated results

LifeTECH Corp. reports results for fiscal year 1996 and first quarter 1997

Cel-Sci six-month clinical update

EntreMed reports fiscal 1996 year-end results and receives U.S. patent

Biomira announces fourth-quarter and 1996 results

Imutec Pharma announces third-quarter results

Ribozyme Pharmaceuticals reports fourth-quarter and year-end financial results

Interferon Sciences reports 1996 operating results and clinical status update

OXIS International reports fiscal year-end results

Aquila Biopharmaceuticals reports fourth-quarter and 1996 year-end financial results

Cobalt porphyrins for obesity from Warner-Lambert

Novel antiemetic reported by Dainippon

Mitsubishi Chemical describes thrombin inhibitors

PGE2 agonists/antagonists from Ono

T-686 inhibits PAI-1 and development of atherosclerotic lesions

Inogatran exerts selective inhibition of thrombin in vitro

Taiho claims nitroimidazoles with antiangiogenic and contrast-enhancing effects

Chronic MK-677 increases GH and IGF-I in dogs

Clinical comparison of cromolyn and furosemide in asthmatics

Gene Logic/Johns Hopkins collaborate on schizophrenia and depression gene discovery

Eagle licenses biotin technology from University of Washington

Genes involved in marijuana abuse

Human skin equivalent approved in Canada

Component of olive oil demonstrates antioxidant and lipoxygenase-inhibitory effects

Hybridon receives clearance to initiate further GEM-132 trials

PEG-rHuMGDF safe and effective for chemotherapy-induced thrombocytopenia

Nigella sativa plant extract exerts antiangiogenic activity

Triangle Pharmaceuticals exercises option to acquire MKC-442

RPR's Tilade approved for pediatric use

Pharmacia & Upjohn's Rescriptor cleared by FDA

Connetics commences phase III trial for betamethasone mousse

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...